PUBLISHER: The Business Research Company | PRODUCT CODE: 1945425
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945425
Intravenous therapy and vein access devices involve tools such as catheters and needles that allow fluids, medications, nutrients, and blood products to be administered directly into the bloodstream for precise and continuous medical care.
The key categories in the intravenous therapy and vein access devices market include intravenous (IV) therapy and vein access implantable ports, intravenous (IV) therapy and vein access intravenous catheters, hypodermic intravenous (IV) therapy and vein access needles, intravenous (IV) therapy and vein access infusion pumps, and others. Intravenous therapy and vein access implantable ports are compact devices implanted beneath the skin to provide long-term, reliable IV access, supporting repeated treatments while reducing discomfort from frequent needle insertions. The applications include volume expansion, medication delivery, blood products, nutritional solutions, and buffer solutions, and the end users include hospitals, clinics, and ambulatory surgical centers.
Tariffs are impacting the intravenous therapy and vein access devices market by increasing the cost of imported catheters, needles, infusion pumps, and implantable ports. Segments such as advanced infusion pumps and implantable ports are most impacted, with Asia-Pacific regions including China and India facing higher import duties. This has led to elevated production costs and supply chain adjustments. On the positive side, tariffs have promoted local manufacturing, encouraged innovation in device design, and boosted domestic production capabilities.
The intravenous therapy and vein access devices market research report is one of a series of new reports from The Business Research Company that provides intravenous therapy and vein access devices market statistics, including intravenous therapy and vein access devices industry global market size, regional shares, competitors with a intravenous therapy and vein access devices market share, detailed intravenous therapy and vein access devices market segments, market trends and opportunities, and any further data you may need to thrive in the intravenous therapy and vein access devices industry. This intravenous therapy and vein access devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The intravenous therapy and vein access devices market size has grown strongly in recent years. It will grow from $33.15 billion in 2025 to $35.79 billion in 2026 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to limited availability of advanced iv therapy devices, reliance on conventional catheters and needles, growing hospital and clinic infrastructure, increasing demand for blood-based products and medication administration, awareness of infection control protocols.
The intravenous therapy and vein access devices market size is expected to see strong growth in the next few years. It will grow to $48.1 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to development of implantable ports and advanced infusion pumps, rising adoption of needleless connectors and iv administration sets, expansion of ambulatory surgical centers, integration of smart monitoring and digital solutions, increasing investment in patient safety and regulatory compliance. Major trends in the forecast period include rising demand for peripheral and central venous access devices, increasing adoption of safety-engineered needles and catheters, growth in infusion pump technologies and patient-controlled analgesia systems, expansion of nutrition and medication administration applications, enhanced focus on sterility, accuracy, and regulatory compliance.
The increasing number of surgical procedures is increasingly supporting the expansion of the intravenous therapy and vein access devices market going forward. The rising demand for elective surgeries, including cosmetic procedures, plastic surgery, rhinoplasty, and other non-essential surgical interventions, has contributed significantly to the overall increase in surgical volumes. Intravenous therapy and vein access devices play a critical role in surgical settings by enabling the administration of anesthesia, medications, fluids, and nutrients, maintaining patient stability, and allowing rapid medical intervention when required. For example, in June 2024, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based nonprofit professional organization, the total number of surgical and non-surgical procedures increased by 3.4% in 2023 to reach 34.9 million. This increase was supported by a 5.5% rise in surgical procedures, with plastic surgeons performing over 15.8 million surgical procedures and 19.1 million non-surgical procedures, representing a 40% overall increase over the past four years. As a result, the growing volume of surgical procedures is contributing to the expansion of the intravenous therapy and vein access devices market.
Leading companies operating in the intravenous therapy and vein access devices market are developing short peripheral intravenous catheters to improve patient comfort, reduce insertion-related complications, and enhance the efficiency of fluid and medication delivery. Short peripheral intravenous catheters provide rapid and reliable venous access for administering fluids, medications, and nutrients while minimizing discomfort and lowering infection risk. For example, in October 2023, B. Braun, a Germany-based medical device company, launched the Introcan Safety 2 IV Catheter. This short peripheral catheter features passive needlestick prevention and a Multi-Access blood control septum, providing automatic needlestick protection and minimizing exposure to bloodborne pathogens each time the hub is accessed.
In June 2023, Merit Medical Systems, Inc., a US-based healthcare technology company, acquired the dialysis catheter product portfolio and the BioSentry Biopsy Tract Sealant System from AngioDynamics, Inc. for an undisclosed amount. Through this acquisition, Merit Medical aimed to strategically broaden its product portfolio in key markets, particularly dialysis and biopsy. AngioDynamics, Inc. is a US-based medical device company that supplies products for intravenous therapy, vein access, and other medical applications.
Major companies operating in the intravenous therapy and vein access devices market are Cardinal Health Inc., Johnson & Johnson Services Inc., 3M Company, Medtronic plc, Becton Dickinson and Company, Baxter International Inc., B Braun Holding GmbH Co KG, Fresenius Kabi AG, Terumo Corporation, West Pharmaceutical Services Inc., ICU Medical Inc., Merit Medical Systems Inc., Avanos Medical Inc., Vygon SAS, AngioDynamics Inc., Elcam Medical Inc., Teleflex Incorporated, Smiths Medical, Nipro Corporation, Argon Medical Devices Inc., Angiplast Private Limited, Poly Medicure Limited, Iradimed Corporation
North America was the largest region in the intravenous therapy and vein access devices market in 2025. The regions covered in the intravenous therapy and vein access devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the intravenous therapy and vein access devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The intravenous therapy and vein access devices market consists of revenues earned by entities by providing services such as catheter insertion, intravenous administration, device maintenance, sterilization, training for healthcare professionals. The market value includes the value of related goods sold by the service provider or included within the service offering. The intravenous therapy and vein access devices market also includes sales of catheters, infusion pumps, and needleless connectors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Intravenous Therapy And Vein Access Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses intravenous therapy and vein access devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for intravenous therapy and vein access devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intravenous therapy and vein access devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.